TP53 and cancer: Even mutations in the TP53 gene, Kras activation and loss of APC that are powerful drivers of clonal expansion in other tissues and almost omnipresent in a large portion of cancers had significantly reduced ability to promote selection and clonal expansion in gut epithelia.